Institute of Immunology and Immunotherapy Immunology is at the forefront of medical research and we are among the leaders of this exciting, fast-evolving field.
News New NoriZite™ Nasal Spray launches in the UK Award-winning innovation from Birmingham Biotech Ltd and University of Birmingham is now available in the UK
22 October 2021 A third of leukaemia patients do not generate any antibody response to two doses of COVID-19 vaccination, study shows A University of Birmingham-led study has shown that a third of patients with the most common type of leukaemia fail to generate any measurable antibody response following two doses of COVID-19 vaccination.
11 October 2021 Milestone moment for the region's life science sector as construction on No. 1 Birmingham Health Innovation Campus gets underway Construction of No.1 Birmingham Health Innovation Campus (BHIC) in Selly Oak is underway, marking a major milestone for the region's rapidly growing life sciences sector.
16 September 2021 Research provides new insight into fundamental workings of the immune system in response to therapy to treat skin cancer New research suggests that skin cancer patients could have a better prognosis if their T cells send messages from five specific genes in their immune response to drugs given to treat the disease.
14 September 2021 University of Birmingham scientists in new COVID-19 study University of Birmingham researchers are part of a new study seeking to understand why some people become infected with COVID-19 after vaccination or prior infection while others do not.
29 July 2021 Birmingham cancer project enters Immuno-oncology Alliance Birmingham researchers partnered with Cancer Research UK in one of the first target identification projects for the Immuno-oncology Alliance, which translates discovery science into new therapeutics for cancer patients.
23 July 2021 Longer interval between the first and second Pfizer vaccine boosts antibody levels and 'helper' T cells A new study carried out in collaboration with the University of Birmingham shows both short and long dosing schedules of the Pfizer COVID-19 vaccine generate strong antibody and T cell immune responses.
13 July 2021 Partnership will create the next generation of researchers to transform global healthcare The Universities of Birmingham, Leicester and Nottingham have launched a partnership training the next generation of leading researchers the skills required to transform our understanding and treatment of disease.